Vitable Health

-63%

est. 2Y upside i

HealthcareSeries A

Affordable care via ICHRA and primary care with visits, meds, labs…

Rank

#3422

Sector

Healthcare

Est. Liquidity

~3Y

Data Quality

Data: Low

This is a high-risk, low-confidence opportunity.

Last updated: July 3, 2026

Bull (15%)0%

Exit multiple holds at 4x due to IPO window; projected revenue $24M gives $96M exit. After 20% dilution, net upside ~0%.

Base (40%)-45%

Multiple compresses to 2.5x, exit value $60M; after dilution, ~-45%.

Bear (45%)-100%

Multiple falls to 1x, exit $24M below $25M liquidation preference; common stock wiped out.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

3125%

Total funding $25M vs. estimated $80M valuation gives 31% preference overhang; in a downside exit, common stock recovers $0.

Dilution Risk

high

Burn rate inferred from total funding and size suggests a raise within 24 months; assumed 20% dilution.

Secondary Liquidity

none

No secondary market activity detected; liquidity likely only via exit.

Other — 9 roles

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Vitable Health's data — designed to show you've done your homework.

1
“How does Vitable's vertically integrated model defend against health insurance incumbents like Cigna and Aetna?”
2
“What is the unit economics and customer acquisition cost for typical hourly-worker employers?”
3
“Given the Series A was 2 years ago, what is the expected timeline and path to profitability or next funding round?”

Our model estimates -63% upside. What do you think?

Anonymous. Do not share material non-public information.

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.